3rd Circ. Affirms Plavix Injury Dismissals in NJ

Law360, New York (November 18, 2013, 8:39 PM EST) -- The Third Circuit on Monday upheld a New Jersey federal court's dismissal of two suits against drugmakers Bristol-Myers Squibb Co. and Sanofi-Aventis US LLC over injuries and deaths allegedly caused by anti-clotting drug Plavix.

A three-judge panel affirmed decisions by U.S. District Judge Freda L. Wolfson granting summary judgment for the defendants in the failure-to-warn suits — one filed by the widow of a patient who died from bleeding caused by Plavix and another by a Plavix consumer who suffered from gastrointestinal bleeding.

The panel found that widow Eloise Labarre had not sufficiently pleaded her claim that the defendants did not...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!